Among them, two independent exome-sequencing studies [19,22] reported a high frequency of mutations in NOTCH1 (29% and 50%, respectively) and NOTCH2 (26% and 67%, respectively) genes, mostly relating to loss of function, thus suggesting their tumor-suppressor role in BCC. This evidence concerns the gene NOTCH1 and skin basal cell carcinoma.